NADAC acquisition cost data for ADAPALENE 0.1% GEL. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
| 68462040355 | $2.50 | 2022-02-23 | Rx |
Generic: Adapalene | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $1.6M | 10,033 | 5,578 | $3.09 |
| 2020 | $1.9M | 11,325 | 5,885 | $3.05 |
| 2021 | $2.5M | 11,780 | 5,495 | $3.50 |
| 2022 | $4.4M | 8,476 | 4,037 | $7.76 |
| 2023 | $2.9M | 8,847 | 4,155 | $4.74 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $1.7M | 1,100 | 497 |
| California | $113.3K | 910 | 466 |
| Michigan | $86.9K | 670 | 338 |
| Texas | $78.5K | 413 | 222 |
| Florida | $70.1K | 476 | 233 |
| Pennsylvania | $68.8K | 482 | 195 |
| North Carolina | $62.2K | 375 | 156 |
| Wisconsin | $49.0K | 328 | 142 |
| Massachusetts | $47.4K | 240 | 115 |
| Ohio | $44.3K | 281 | 119 |
| Missouri | $42.0K | 222 | 89 |
| Minnesota | $40.7K | 275 | 131 |
| New Jersey | $37.1K | 262 | 130 |
| Virginia | $33.3K | 189 | 98 |
| Maryland | $28.8K | 220 | 104 |
| Connecticut | $27.6K | 189 | 62 |
| Illinois | $27.3K | 152 | 74 |
| Washington | $25.8K | 191 | 82 |
| Georgia | $25.3K | 166 | 98 |
| Indiana | $23.9K | 160 | 89 |
| Tennessee | $20.4K | 159 | 74 |
| South Carolina | $16.6K | 116 | 59 |
| Louisiana | $15.2K | 95 | 37 |
| Puerto Rico | $13.5K | 85 | 44 |
| Colorado | $12.7K | 103 | 52 |
| Arizona | $12.4K | 94 | 44 |
| Kansas | $11.4K | 53 | 27 |
| Alabama | $9.8K | 75 | 37 |
| Utah | $8.4K | 62 | 31 |
| Hawaii | $7.2K | 71 | 36 |
| South Dakota | $7.2K | 41 | 13 |
| Iowa | $7.1K | 53 | 25 |
| Kentucky | $6.9K | 28 | 25 |
| New Hampshire | $6.9K | 41 | 22 |
| Nebraska | $6.5K | 36 | 17 |
| Nevada | $6.3K | 37 | 20 |
| District of Columbia | $6.3K | 52 | 28 |
| Oregon | $5.6K | 49 | 26 |
| Arkansas | $5.6K | 35 | 13 |
| Montana | $4.9K | 29 | 11 |
| Maine | $4.7K | 36 | 12 |
| New Mexico | $4.5K | 26 | 12 |
| Rhode Island | $4.3K | 23 | N/A |
| Oklahoma | $4.2K | 26 | 13 |
| Idaho | $3.8K | 33 | 19 |
| Delaware | $3.4K | 20 | N/A |
| West Virginia | $3.2K | 23 | 18 |
| North Dakota | $2.6K | 19 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.